Maarten J. Titulaer

24.7k total citations · 7 hit papers
120 papers, 11.5k citations indexed

About

Maarten J. Titulaer is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Maarten J. Titulaer has authored 120 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Neurology, 29 papers in Genetics and 17 papers in Molecular Biology. Recurrent topics in Maarten J. Titulaer's work include Autoimmune Neurological Disorders and Treatments (98 papers), Peripheral Neuropathies and Disorders (60 papers) and Genetics and Neurodevelopmental Disorders (28 papers). Maarten J. Titulaer is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (98 papers), Peripheral Neuropathies and Disorders (60 papers) and Genetics and Neurodevelopmental Disorders (28 papers). Maarten J. Titulaer collaborates with scholars based in Netherlands, United States and Spain. Maarten J. Titulaer's co-authors include Josep Dalmau, Francesc Graus, Jan J.G.M. Verschuuren, Myrna R. Rosenfeld, Thaís Armangué, Núria Gresa‐Arribas, Rita J. Balice‐Gordon, Lindsey McCracken, Frank Leypoldt and Peter A.E. Sillevis Smitt and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Maarten J. Titulaer

116 papers receiving 11.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

2013 2.0k citations Maarten J. Titulaer, Albert Saiz et al. profile →
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

2013 670 citations Maarten J. Titulaer, Frank Leypoldt et al. profile →
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models

2019 498 citations Josep Dalmau, Frank Leypoldt et al. profile →
Anti-LGI1 encephalitis

2016 408 citations Agnes van Sonderen, Marienke A.A.M. de Bruijn et al. Neurology profile →
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies

2014 404 citations Maarten J. Titulaer, Francesc Graus et al. profile →
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes

2021 357 citations Francesc Graus, Divyanshu Dubey et al. Neurology Neuroimmunology & Neuroinflammation profile →
Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice

2014 344 citations Frank Leypoldt, Maarten J. Titulaer et al. profile →

Peers

Countries citing papers authored by Maarten J. Titulaer

Since Specialization

Citations

This map shows the geographic impact of Maarten J. Titulaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten J. Titulaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten J. Titulaer more than expected).

Fields of papers citing papers by Maarten J. Titulaer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten J. Titulaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten J. Titulaer. The network helps show where Maarten J. Titulaer may publish in the future.

Co-authorship network of co-authors of Maarten J. Titulaer

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten J. Titulaer. A scholar is included among the top collaborators of Maarten J. Titulaer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten J. Titulaer. Maarten J. Titulaer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote 2025 ·Journal of Neuroimmunology ·(unknown), Tammy Smith, (unknown), Ka‐Ho Wong, Lisa K. Peterson, Αναστασία Ζεκερίδου, (unknown), Christopher S. Coffey, (unknown), (unknown), (unknown), Susan Flavin, (unknown), Maarten J. Titulaer, Gregory S. Day, Stacey Clardy	3
2	Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real‐world cohort study 2025 ·Annals of Clinical and Translational Neurology ·(unknown), (unknown), Juna M. de Vries, Ide Smets, Robert M. Verdijk, (unknown), (unknown), (unknown), (unknown), Marjolein Geurts, Jacoline E. C. Bromberg, Corine H. GeurtsvanKessel, Peter A. Sillevis Smitt, Rutger K. Balvers, Maarten J. Titulaer	1
3	The Clinical Trial Landscape in Autoimmune Encephalitis 2025 ·Neurology ·Hesham Abboud, Stacey Clardy, Divyanshu Dubey, Jonathan Wickel, Gregory S. Day, Christian Geis, Jeffrey M. Gelfand, Sarosh R. Irani, Soon‐Tae Lee, Maarten J. Titulaer	4
4	Autoimmune encephalitis 2025 ·Nature Reviews Disease Primers ·Marienke A.A.M. de Bruijn, Frank Leypoldt, Josep Dalmau, Soon‐Tae Lee, Jérôme Honnorat, Stacey Clardy, Sarosh R. Irani, Ava Easton, Amy Kunchok, Maarten J. Titulaer	1
5	High Relapse Rate in Anti-CASPR2 Disease 2025 ·Neurology Neuroimmunology & Neuroinflammation ·(unknown), (unknown), Marie Vermeiren, Agnes van Sonderen, (unknown), (unknown), (unknown), (unknown), (unknown), Peter A.E. Sillevis Smitt, Sharon Veenbergen, Dave L. Roelen, Maarten J. Titulaer, Juna M. de Vries	0
6	Inter‐Laboratory Validation of Nodal/Paranodal Antibody Testing 2025 ·Journal of the Peripheral Nervous System ·Cinta Lleixà, Maarten J. Titulaer, (unknown), (unknown), Susan K. Halstead, Janev Fehmi, Elba Pascual‐Goñi, (unknown), Luise Appeltshauser, (unknown), Manuela Paunovic, Patrick Waters, Hugh J. Willison, Claudia Sommer, Luís Querol, Ruth Huizinga, Kathrin Doppler, Simon Rinaldi	3
7	Anti-N-methyl-d-aspartate receptor encephalitis: insights and future treatment directions 2025 ·Trends in Molecular Medicine ·(unknown), Tammy Smith, Melissa A. Wright, Gregory S. Day, Maarten J. Titulaer, Stacey Clardy	0
8	Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature 2024 ·Journal of Neuroimmunology ·Melissa A. Wright, Mar Guasp, Christian Lachner, Gregory S. Day, Grace Gombolay, Maarten J. Titulaer, Stacey Clardy	2
9	Antibodies Associated With Autoimmune Encephalitis in Patients With Presumed Neurodegenerative Dementia 2023 ·Neurology Neuroimmunology & Neuroinflammation ·Anna E.M. Bastiaansen, (unknown), (unknown), Wiesje M. van der Flier, Charlotte E. Teunissen, Esther de Graaff, Mariska M.P. Nagtzaam, Manuela Paunovic, (unknown), Marco W.J. Schreurs, Frank Leypoldt, Peter A.E. Sillevis Smitt, Juna M. de Vries, Harro Seelaar, John C. van Swieten, Frank Jan de Jong, Yolande A.L. Pijnenburg, Maarten J. Titulaer	17
10	The First Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of an FcRn Inhibitor, Rozanolixizumab, in Patients With Leucine-Rich Gliomainactivated 1 Autoimmune Encephalitis 2022 ·Neurology ·Divyanshu Dubey, Maarten J. Titulaer, (unknown), (unknown), Sarosh R. Irani	5
11	Seizures in adults with suspected central nervous system infection 2022 ·BMC Neurology ·(unknown), Ingeborg E. van Zeggeren, Liora ter Horst, (unknown), (unknown), Björn M. van Geel, S.G.B. Heckenberg, Korné Jellema, (unknown), Joep Killestein, (unknown), Maarten J. Titulaer, K.E.B. van Veen, Constant V.M. Verschuur, Diederik van de Beek, Matthijs C. Brouwer	6
12	The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis 2022 ·Neurology ·Ka‐Ho Wong, Gregory S. Day, Maarten J. Titulaer, James C. Torner, Merit Cudkowicz, Christopher S. Coffey, Codrin Lungu, Eric C. Klawiter, (unknown), (unknown), (unknown), Dixie Ecklund, (unknown), Michele Costigan, Stacey Clardy	1
13	No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy 2021 ·Pathogens ·An Hotterbeekx, (unknown), Melanie Ramberger, (unknown), (unknown), Floribert Tepage, (unknown), Samir Kumar‐Singh, Maarten J. Titulaer, Robert Colebunders	18
14	Pediatric autoimmune encephalitis 2020 ·Neurology Neuroimmunology & Neuroinflammation ·Marienke A.A.M. de Bruijn, Arlette L. Bruijstens, Anna E.M. Bastiaansen, Agnes van Sonderen, Marco W.J. Schreurs, Peter A.E. Sillevis Smitt, Rogier Q. Hintzen, Rinze F. Neuteboom, Maarten J. Titulaer	38
15	Encephalitis and AMPA receptor antibodies 2015 ·Neurology ·Romana Höftberger, Agnes van Sonderen, Frank Leypoldt, David Houghton, Michael D. Geschwind, Jeffrey M. Gelfand, Mercedes F. Paredes, Lídia Sabater, Albert Saiz, Maarten J. Titulaer, Francesc Graus, Josep Dalmau	243
16	Antibodies to active zone protein ERC1 in Lambert–Eaton myasthenic syndrome 2013 ·Human Immunology ·Maartje G. Huijbers, Alexander F. Lipka, Marko Potman, Paul J. Hensbergen, Maarten J. Titulaer, E. Niks, Silvère M. van der Maarel, Rinse Klooster, Jan J.G.M. Verschuuren	9
17	Clinical Dutch-English Lambert-Eaton Myasthenic Syndrome (LEMS) Tumor Association Prediction Score Accurately Predicts Small-Cell Lung Cancer in the LEMS 2011 ·Journal of Clinical Oncology ·Maarten J. Titulaer, Paul Maddison, Jacob K. Sont, Paul W. Wirtz, David Hilton‐Jones, Rinse Klooster, Nick Willcox, Marko Potman, Peter A.E. Sillevis Smitt, Jan B. M. Kuks, Bart O. Roep, Angela Vincent, Silvère M. van der Maarel, J. Gert van Dijk, Bethan Lang, Jan J.G.M. Verschuuren	117
18	The Presence of Autoantibodies to Tumour-Associated Antigens Can Predate Clinical Diagnosis of Small Cell Lung Cancer 2010 ·CHEST Journal ·Caroline Chapman, J.F.R. Robertson, Andrea Murray, Maarten J. Titulaer, Bethan Lang, (unknown), (unknown), Jan J.G.M. Verschuuren, Paul Maddison	5
19	The Lambert–Eaton myasthenic syndrome 1988–2008: A clinical picture in 97 patients 2008 ·Journal of Neuroimmunology ·Maarten J. Titulaer, Paul W. Wirtz, Jan B. M. Kuks, Helenius J. Schelhaas, Anneke J. van der Kooi, Catharina G. Faber, W. Ludo van der Pol, Marianne de Visser, Peter A.E. Sillevis Smitt, Jan J.G.M. Verschuuren	83
20	Lambert–Eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel 2008 ·Journal of Neuroimmunology ·Hannah Pellkofer, (unknown), Markus Krumbholz, Maarten J. Titulaer, Jan J.G.M. Verschuuren, (unknown), Raymond Voltz	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact